EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence and cytopathology: Where are we heading?

Bryn Nelson, William Faquin

Cancer Cytopathology · 2023-06 · 131 (6) · 342-343

DOI: 10.1002/cncy.22724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 02.06.2023. Verfasst von Bryn Nelson und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Artificial Intelligence, Algorithms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this first of a two‐part series, whether you are intrigued or alarmed by the emergency of artificial intelligence (AI), a recent burst of research in AI is showing how the algorithms can expand and might shift responsibilities for the cytology workforce, even as multiple challenges remain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceAlgorithmsFemaleHumansCytodiagnosisCytological Techniques

Zitieren

APA

Nelson, B., & Faquin, W. (2023). Artificial intelligence and cytopathology: Where are we heading?. Cancer Cytopathology, 131(6), 342-343. https://doi.org/10.1002/cncy.22724

Vancouver

Nelson B, Faquin W. Artificial intelligence and cytopathology: Where are we heading?. Cancer Cytopathology. 2023;131(6):342-343. doi:10.1002/cncy.22724

BibTeX
@article{Nelson2023,
  author = {Nelson, Bryn and Faquin, William},
  title = {Artificial intelligence and cytopathology: Where are we heading?},
  journal = {Cancer Cytopathology},
  year = {2023},
  volume = {131},
  number = {6},
  pages = {342--343},
  doi = {10.1002/cncy.22724}
}
Kostenlos starten →